-
STAT News – Biotech3 weeks agoSTAT+: Medicare chief says TrumpRx is meant to be narrow in scope
At yesterday’s STAT Breakthrough Summit East, Medicare chief Chris Klomp offered a tempered view of TrumpRx, and an MSK cell therapy expert warned that China’s more...
-
Endpoints News3 weeks ago
Sarepta to ask FDA for full approval of exon skipping drugs; Rhythm’s label expansion in rare form of obesity
Plus, news about Gilead, Assembly Biosciences and Pfizer: 📁 Sarepta says FDA open to a filing for full approval of two Duchenne drugs: After a failed...
-
Endpoints News3 weeks ago
China-rooted AI biotech Earendil Labs raises $787M ahead of possible IPO
The US-headquartered, China-rooted biotech Earendil Labs said it has raised $787 million in private money, a whopping sum to fund an AI platform that has already...
-
Fierce Biotech3 weeks ago
Oryon shines out of stealth with $21M to fight Parkinson’s disease
When Ron Cohen, M.D., CEO of Oryon Cell Therapies, recently dug into the company’s Parkinson’s disease data, he told Fierce Biotech it “sang” to him. The...
-
STAT News – Biotech3 weeks agoSTAT+: Up and down the ladder: The latest comings and goings
Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send...
-
Endpoints News3 weeks ago
UK’s NICE revisits Lilly, Eisai Alzheimer’s drugs under new pricing threshold
The UK’s drug watchdog is reconsidering two Alzheimer’s disease medicines after rejecting them for being too expensive. The National Institute for Health and Care Excellence last...
-
BioPharma Dive – AI / Data3 weeks agoNovartis pays $2B to land a startup’s breast cancer drug
Acquiring a unit of privately held Synnovation Therapeutics hands Novartis a prospect that might improve on medicines that, like its own Piqray, target tumors driven to...
-
STAT News – Biotech3 weeks agoA conversation with the ‘godfather’ of biotech
On this week’s episode of “The Readout LOUD,” we bring you a special conversation with Stelios Papadopolous, also know as the “godfather” of biotech. He sat...
-
AI & Machine Learning in Biotechnology3 weeks agoAll the highlights from STAT’s Breakthrough Summit East
Good morning and happy Friday. I’m off today, but I’ll talk to you next week. Highlights from yesterday’s summit For me, the top moment from yesterday’s...
-
Fierce Biotech3 weeks ago
Genentech antibody fails to boost muscle in rare diseases, raising questions for obesity trial
Genentech is halting development of an antibody for two rare genetic diseases after the candidate failed to boost muscle growth, raising questions about whether the molecule...
Terns rebuffed a higher bid before selling to Merck
